Complex visual hallucinations. Clinical and neurobiological insights

Brain

Volumn 121, Issue 10, 1998, Pages 1819-1840

  Manford, M ^a   Andermann, F ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Arousal; Serotonin; Thalamocortical; Visual hallucinations

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; CLOZAPINE; LEVODOPA; METHYSERGIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; ONDANSETRON; PIZOTIFEN; PROTRIPTYLINE; RISPERIDONE;

ADULT; AGED; BRAIN INJURY; BRAIN STEM; CATAPLEXY; CHARLES BONNET SYNDROME; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL FEATURE; COMA; DEMENTIA; DYSKINESIA; EPILEPSY; FEMALE; HUMAN; LEWY BODY; MALE; MIGRAINE; NARCOLEPSY; NEUROBIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SLEEP; SLEEP DISORDER; STEREOTYPY; THALAMOCORTICAL TRACT; VISION; VISUAL CORTEX; VISUAL HALLUCINATION; VISUAL SYSTEM;

EID: 0031712490     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.10.1819     Document Type: Review

References (207)

1. Aggernaes A. The difference between the experienced reality of hallucinations in young drug abusers and schizophrenic patients. Acta Psychiatr Scand 1972; 48: 287-99.
2. Alajouanine Th, Gopcevitch V. Hallucinose préhypnique, automatisme ambulatoire et verbal nocturne, éclipses confusionelles paroxystiques chez une malade atteinte d'un syndrome parkinsonien postencéphalitique, avec syndrome Parinaud respectent les mouvements automatico-réflexes, et crises toniques des membres à type de crampes vespérales. Rev Neurol (Paris) 1928; 2: 714-8.
3. Alajouanine Th, Thurel R, Durupt L. Lesion protruberantielle basse d'origine vasculaire et hallucinose. Rev Neurol (Paris) 1944; 76: 90-1.
4. Aldrich MS. Parkinsonism. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 2nd ed. Philadelphia: W.B. Saunders. 1994. p. 783-8.
5. Aldrich MS, Naylor MW. Narcolepsy associated with lesions of the diencephalon. Neurology 1989; 39: 1505-8.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington (DC): American Psychiatric Association; 1994.
7. Andermann F. Clinical features of migraine-epilepsy syndromes. In: Andermann F, Lugaresi E, editors. Migraine and epilepsy. Boston: Butterworths; 1987. p. 3-30.
8. Angrist B, Sathananthan G, Wilk S, Gershon S. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 1974; 11: 13-23.
9. Asaad G, Shapiro B. Hallucinations: theoretical and clinical overview. [Review]. Am J Psychiatry 1986; 143: 1088-97.
10. Askenasy JJ, Yahr MD. Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy. Neurology 1985; 35: 527-32.
11. Autret A, Lucas B, Henry-Lebras F, Toffol B. Symptomatic narcolepsies. [Review]. Sleep 1994; 17 (8 Suppl): S21-4.
12. Baillarger J. De l'influence de l'état intermédiaire à la veille et au sommeil sur la prodution et la marche des hallucinations. Mem Acad de Med Par 1846; 12: 476-516.
13. Bail B, De l'insanité dans la paralysie agitante. Encephale 1882; 2: 22-52.
14. Bancaud J, Brunet-Bourgin F, Chauvel P, Halgren E. Anatomical origin of déjà vu and vivid 'memories' in human temporal lobe epilepsy. Brain 1994; 117: 71-90.
15. Baska RE. Hypothalamic-midbrain dysregulation syndrome [letter; comment]. J Child Neurol 1992; 7: 116-7. Comment on: J Child Neurol 1991; 6: 115-22.
16. Baska RE. Hypothalamic-midbrain dysregulation syndrome [letter; comment]. J Child Neurol 1992; 7: 116-7. Comment on: J Child Neurol 1991; 6: 115-22.
17. Bassetti C, Mathis J, Gugger M, Lovblad KO, Hess CW. Hypersomnia following paramedian thalamic stroke: a report of 12 patients. Ann Neurol 1996; 39: 471-80.
18. Baumgartner GR, Rowen RC. Cionidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 1987; 147: 1223-6.
19. Beaumanoir A, Jekiel M. Electrographic observations during attacks of classical migraine. In: Andermann F, Lugaresi E, editors. Migraine and Epilepsy. Boston: Butterworths; 1987. p. 163-80.
20. Beckstead RM, Long collateral branches of substantia nigra pars reticulata axons to thalamus, superior colliculus and reticular formation in monkey and cat. Multiple retrograde neuronal labeling with fluorescent dyes. Neuroscience 1983; 10: 767-79.
21. Beckstead RM, Domesick VB, Nauta WJ. Efferent connections of the substantia nigra and ventral tegniental area in the rat. Brain Res 1979; 175: 191-217.
22. Beninato M, Spencer RF. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus. Brain Res 1987; 412: 169-74.
23. Bliss EL, Clark LD. Visual hallucinations. In: West LJ, editor. Hallucinations. New York: Grune & Stratton. 1963. p. 92-107.
24. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. [Review]. Trends Neurosci 1990; 13: 296-302.
25. Bracha HS, Wolkowitz OM, Lohr JB, Karson CN, Bigelow LB. High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry 1989; 146: 526-8.
26. Carpenter WT, Jr., Buchanan RW. Schizophrenia [see comments]. [Review]. N Engl J Med 1994; 330: 681-90. Comment in: N Engl J Med 1994; 331: 275-6.
27. Carpenter WT, Jr., Buchanan RW. Schizophrenia [see comments]. [Review]. N Engl J Med 1994; 330: 681-90. Comment in: N Engl J Med 1994; 331: 275-6.
28. Castaigne P, Lhermitte F, Buge A, Escourolle R, Hauw JJ, Lyon-Caen O. Paramedian thalamic and midbrain infarct: clinical and neuropathological study. Ann Neurol 1981; 10: 127-48.
29. Celesia GG, Barr AN. Psychosis and other psychiatric manifestations of levodopa therapy. Arch Neurol 1970; 23: 193-200.
30. Chan AW. Alcoholism and epilepsy. [Review], Epilepsia 1985; 26: 323-33.
31. Chaturvedi N, Hedley-Whyte ET, Dreyer EB. Lateral geniculate nucleus in glaucoma [see comments]. Am J Ophthalmol 1993; 116: 182-8. Comment in: Am J Ophthalmol 1993; 116: 182-8.
32. Chaturvedi N, Hedley-Whyte ET, Dreyer EB. Lateral geniculate nucleus in glaucoma [see comments]. Am J Ophthalmol 1993; 116: 182-8. Comment in: Am J Ophthalmol 1993; 116: 182-8.
33. Cheng AV, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, et al. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. J Neurol Sci 1991; 106: 50-5.
34. Chua SE, McKenna PJ. Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. [Review]. Br J Psychiatry 1995; 166: 563-82.
35. Codina A, Acarin PN, Miquel F, Noguera M. Familial hemiplegic migraine associated with nystagmus. [French]. Rev Neurol (Paris) 1971; 124: 526-30.
36. Cogan DG. Visual hallucinations as release phenomena. Albrecht von Graefes Arch Klin Exp Ophthalmol 1973; 188: 139-50.
37. Cornella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993; 34: 710-4.
38. Cowey A, Stoerig P. The neurobiology of blindsight. [Review]. Trends Neurosci 1991; 14: 140-5.
39. Cusick CG, Scripter JL, Darensbourg JG, Weber JT. Chemoarchitectonic subdivisions of the visual pulvinar in monkeys and their connectional relations with the middle temporal and rostral dorsolateral visual areas, MT and DLr. J Comp Neurol 1993; 336: 1-30.
40. Cutrer FM, Sorensen AG, Weisskopf RM, Ostergaard L, Sanchez del Rio M, Lee EJ, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998; 43: 25-31.
41. Damasio AR, Lobo-Antunes J, Macedo C. Psychiatric aspects in parkinsonism treated with L-dopa. J Neurol Neurosurg Psychiatry 1971; 34: 502-7.
42. Davis KD, Kiss ZH, Luo L, Tasker RR, Lozano AM, Dostrovsky JO. Phantom sensations generated by thalamic microstimulation [see comments]. Nature 1998; 391: 385-7. Comment in: Nature 1998; 391: 331, 333.
43. Davis KD, Kiss ZH, Luo L, Tasker RR, Lozano AM, Dostrovsky JO. Phantom sensations generated by thalamic microstimulation [see comments]. Nature 1998; 391: 385-7. Comment in: Nature 1998; 391: 331, 333.
44. D'Cruz OF, Vaughn BV, Gold SH. Greenwood RS. Symptomatic cataplexy in pontomedullary lesions [published erratum appears in Neurology 1995; 45: 2123]. Neurology 1994; 44: 2189-91.
45. D'Cruz OF, Vaughn BV, Gold SH. Greenwood RS. Symptomatic cataplexy in pontomedullary lesions [published erratum appears in Neurology 1995; 45: 2123]. Neurology 1994; 44: 2189-91.
46. de la Fuente Fernandez R, Lopez J, Rey del Corral P, de la Iglesia Martinez F. Peduncular hallucinosis and right hemiparkinsonism caused by left mesencephalic infarction [letter]. J Neurol Neurosurg Psychiatry 1994; 57: 870.
47. de Smet Y, Ruberg M, Serdaru M, Dubois B, Lhermitte F, Agid Y. Confusion, dementia and anticholinergics in Parkinson's disease. J Neurol Neurosurg Psychiatry 1982; 45: 1161-4.
48. Dubois B, Danze F, Pillon B, Cusimano G, Lhermitte F, Agid Y. Cholinergic-dependent cognitive deficits in Parkinson's disease. Ann Neurol 1987; 22: 26-30.
49. Dubois B, Pillon B, Lhermitte F, Agid Y. Cholinergic deficiency and frontal dysfunction in Parkinson's disease. Ann Neurol 1990; 28: 117-21.
50. Dunn DW, Weisberg LA, Nadell J. Peduncular hallucinations caused by brainstem compression. Neurology 1983; 33: 1360-1.
51. Duyckaerts C, Caspar P, Costa C, Bonnet A-M, Hauw J-J. Dementia in Parkinson's disease: morphometric data. Adv Neurol 1993; 60: 447-55.
52. Fasullo S, Lupo I. Neurophysiopathology of the visual hallucinations in the delirium tremens type of syndrome. [Italian]. Acta Neurol (Napoli) 1973; 28: 471-80.
53. Feinberg WM, Rapcsak SZ. 'Peduncular hallucinosis' following paramedian thalamic infarction. Neurology 1989; 39: 1535-6.
54. Fish DR, Gloor P, Quesney LF, Olivier A. Clinical responses to electrical brain stimulation of the temporal and frontal lobes in patients with epilepsy. Brain 1993; 116: 397-414.
55. Fitzpatrick D, Diamond IT, Raczkowski D. Cholinergic and monoaminergic innervation of the cat's thalamus: comparison of the lateral geniculate nucleus with other principal sensory nuclei. J Comp Neurol 1989; 288: 647-75.
56. Foote SL, Morrison JH. Extrathalamic modulation of cortical function. [Review]. Ann Rev Neurosci 1987; 10: 67-95.
57. Foulkes D, Vogel G. Ego functions and dreaming Mental activity at sleep onset. J Abnorm Psychol 1965; 70: 231-43.
58. Frieske DA, Wilson WP. Formal qualities of hallucinations: a comparative study of the visual hallucinations in patients with schizophrenic, organic, and affective psychoses. Proceedings of the Annual Meeting of the American Psychopathological Association 1966; 54: 49-62.
59. Gaillard J-M, Nicholson AN, Pascoe PA. Neurotransmitter systems. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 2nd ed. Philadelphia: W. B. Saunders; 1994. p. 338-18.
60. Geller TJ, Bellur SN. Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life. Ann Neurol 1987; 21: 602-4.
61. Gibb WRG. The pathology of parkinsonian disorders. In: Quinn NP, Jenner PG, editors. Disorders of movement: clinical, pharmacological and physiological aspects. London: Academic Press; 1989. p. 33-57.
62. Gillin JC, Post RM, Wyatt RJ, Goodwin FK, Snyder F, Bunney WE Jr. REM inhibitory effect of L-DOPA infusion during human sleep. Electroencephalogr Clin Neurophysiol 1973; 35: 181-6.
63. Girard P, Salin PA, Bullier J. Response selectivity of neurons in area MT of the macaque monkey during reversible inactivation of area VI. J Neurophysiol 1992; 67: 1437-46.
64. Glennon RA, Titeler M, McKenney JD. Evidence for 5HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 1984; 35: 2505-11.
65. Gloor P. Experiential phenomena of temporal lobe epilepsy: facts and hypotheses. [Review]. Brain 1990; 113: 1673-94.
66. Gloor P, Olivier A, Quesney LF, Andermann F, Horowitz S. The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982; 12: 129-44.
67. Gold JM, Weinberger DR. Cognitive deficits and the neurobiology of schizophrenia. [Review]. Curr Opin Neurobiol 1995; 5: 225-30.
68. Goodwin DW, Alderson P, Rosenthal R. Clinical significance of hallucinations in psychiatric disorders. A study of 116 hallucinatory patients. Arch Gen Psychiatry 1971; 24: 76-80.
69. Griffith JD. Amphetamine dependence; clinical features. In: Martin WR, editor. Drug addiction II. Amphetamine, psychotogen, and marihuana dependence. Handbook of experimental pharmacology, Vol. 45/II. Berlin: Springer-Verlag; 1977. p. 277-304.
70. Hajdu F, Somogyi G, Tombol T. Neuronal and synaptic arrangement in the lateralis posterior-pulvinar complex of the thalamus in the cat. Brain Res 1974; 73: 89-104.
71. Halgren E, Walter RD, Cherlow DG, Crandall PH. Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain 1978; 101: 83-117.
72. Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res 1990; 510: 104-7.
73. Hartmann E. Psychobiology and dreaming. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 2nd ed. Philadelphia: W. B. Saunders; 1994. p. 373-410.
74. Hemmingsen R, Kramp P, Rafaelsen OJ. Delirium tremens and related clinical states. [Review]. Acta Psychiatr Scand 1979; 59: 337-69.
75. Hishikawa Y, Shimizu T. Physiology of REM sleep, cataplexy, and sleep paralysis. [Review]. Adv Neurol 1995; 67: 245-71.
76. Hishikawa Y, Nan'no H, Tachibana M, Furuya E, Koida H, Kaneko Z. The nature of sleep attack and other symptoms of narcolepsy. Electroencephalogr Clin Neurophysiol 1968; 24: 1-10.
77. Hishikawa Y, Koida H, Yoshino K, Wakamatsu H, Sugita Y, Iijima S, et al. Characteristics of REM sleep accompanied by sleep paralysis and hypnagogic hallucinations in narcoleptic patients. Waking Sleeping 1978; 2: 113-23.
78. Hollister LE. Drug-induced psychoses and schizophrenic reactions; a critical comparison. Ann N Y Acad Sci 1962; 96: 80-8.
79. Horowski R. Psychiatric side-effects of high-dose lisuride therapy in parkinsonism [letter]. Lancet 1986; 2: 510.
80. Howlett DC, Downie AC, Banerjee AK, Tonge KA, Oakeley HF. MRI of an unusual case of peduncular hallucinosis (Lhermitte's syndrome). Neuroradiology 1994; 36: 121-2.
81. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140-8.
82. Isbell H, Altschul S, Kornetsky CH, Eisenman AJ, Flanary HG, Fraser HF. Chronic barbiturate intoxication: an experimental study. Arch Neurol Psychiatry 1950; 64: 1-28.
83. Isbell H, Fraser HF, Wikler A, Belleville RE, Eisenman AJ. An experimental study of the etiology of 'rum fits' and delirium tremens. Quart J Stud Alcohol 1955; 16: 1-33.
84. Jackson A, Crossman AR. Nucleus tegmenti pedunculopontinus: efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase. Neuroscience 1983; 10: 725-65.
85. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. [Review]. Physiol Rev 1992; 72: 165-229.
86. Jacobs BL, Henriksen SJ, Dement WC. Neurochemical bases of the PGO wave. Brain Res 1972; 48: 406-11.
87. Jeanmonod D, Magnin M, Morel A. Low-threshold calcium spike bursts in the human thalamus. Common physiopathology for sensory, motor and limbic positive symptoms. Brain 1996; 119: 363-75.
88. Jellinger K. New developments in the pathology of Parkinson's disease. [Review]. Adv Neurol 1990; 53: 1-16.
89. Johnson J, Milner G. Psychiatric complications of amphetamine substances. Acta Psychiatr Scand 1966; 42: 252-63.
90. Jones BE. Basic mechanisms of sleep-wake states. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 2nd ed. Philadelphia: W. B. Saunders; 1994. p. 145-62.
91. Jones EG, Powell TP. An anatomical study of converging sensory pathways within the cerebral cortex of the monkey. Brain 1970; 93: 793-820.
92. Kahn N, Freeman A, Juncos JL, Manning D, Watts RL. Clozapine is beneficial for psychosis in Parkinson's disease. Neurology 1991; 41: 1699-700.
93. Kaneko Z, Hishikawa Y. Paradoxical sleep in psychiatric disorders and narcolepsy. [Review]. Int J Neurol 1981; 15: 40-55.
94. Kemp JA, Roberts HC, Sillito AM. Further studies on the action of 5-hydroxytryptamine in the dorsal lateral geniculate nucleus of the cat. Brain Res 1982; 246: 334-7.
95. Kolmel HW. Peduncular hallucinations. J Neurol 1991; 238: 457-9.
96. Kolmel HW. Visual illusions and hallucinations. [Review]. Baillieres Clin Neurol 1993; 2: 243-64.
97. Kosaka K. Dementia and neuropathology in Lewy body disease. In: Narabayashi H, Nagatsu T, Yanigasawa N, Mizuno Y, editors. Advances in Neurology. New York: Raven Press; 1993. p. 456-63.
98. Kraus ML, Gottlieb LD, Horwitz RT, Anscher M. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med 1985; 313: 905-9.
99. Kuiper MA, Zwaan WA, Wolters EC. Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease. [Dutch]. Ned Tijdschr Geneeskd 1994; 138: 1353-7.
100. Lalla D, Primeau F. Complex visual hallucinations in macular degeneration. Can J Psychiatry 1993; 38: 584-6.
101. Lance JW. Simple formed hallucinations confined to the area of a specific visual field defect. Brain 1976; 99: 719-34.
102. Lance JW. Current concepts of migraine pathogenesis, [Review]. Neurology 1993; 43 (6 Suppl 3): S11-5.
103. Laurent JP, Rondouin G, Benita M, Jouvet M. Reversible blockade of PGO waves and concomitant modifications of thalamic unit activity in chronic cats. Brain Res 1977; 137: 305-322.
104. Lauritzen M. Cerebral blood flow in migraine and spreading depression. In: Andermann F, Lugaresi E, editors. Migraine and epilepsy. Boston: Butterworths; 1987, p. 325-37.
105. Lauterbach EC. Dopaminergic hallucinosis with fluoxetine in Parkinson's disease [letter]. Am J Psychiatry 1993; 150: 1750.
106. Leaning FE. An introductory study to hypnagogic phenomena. Proc Soc Psychic Res 1926; 35: 288-409.
107. Leao AAP, Morrison RS. Propagation of spreading conical depression. J Neurophysiol 1945; 8: 33-45.
108. Leroy R. The syndrome of Lilliputian hallucinations. J Nerv Ment Dis 1922; 56: 325-33.
109. Lewander T. General pharmacology of amphetamine-like drugs. B: Effects of amphetamines in animals. In: Martin WR, editor. Drug addiction II. Amphetamine, psychotogen, and marihuana dependence. Handbook of experimental pharmacology, Vol. 45/11. Berlin: Springer-Verlag; 1977. p. 33-246.
110. Lewis DJ. Lilliputian hallucinations in the functional psychoses. Canad Psychiat Ass J 1961; 6: 177-201.
111. Lhermitte J. Sydrome de la calotte du Pedoncule cérébral. Les troubles psycho-sensoriels dans les lesions du mésocéphale. Rev Neurol (Paris) 1922; 2: 1359-65.
112. Lhermitte J, Bineau R. Les hallucinations visuelles consecutives aux lesions pédonculaires en foyer. Rev Neurol (Paris) 1937; 68: 827-31.
113. Lhermitte J, Levy G. L'hallucinose pédonculaire (un nouveau cas de lesion de la callotte pédonculaire provoqué par une intoxication aigue par divers narcotiques). Rev Neurol (Paris) 1931; 1: 312-8.
114. Lhermitte J, Levy G, Trelles J. L'hallucinose pédonculaire (étude anatomique d'un cas). Rev Neurol (Paris) 1932; 1: 382-8.
115. Lipowski ZJ. Delirium due to alcohol and drug withdrawal. In: Lipowski ZJ. Delirium: acute brain failure in man. Springfield (IL): Charles C. Thomas; 1980. p. 317-43.
116. Lowe GR. The phenomenology of hallucinations as an aid to differential diagnosis. Br J Psychiatry 1973; 123: 621-33.
117. Luebke JI, Greene RW, Semba K, Kamondi A, McCarley RW, Reiner PB. Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro. Proc Natl Acad Sci USA 1992; 89: 743-7.
118. Mackay AVP, Iversen LL. Neurotransmitters and schizophrenia. In: Weller M, Eysenck M, editors. The scientific basis of psychiatry. London: W. B. Saunders; 1992. p. 558-81.
119. MacKinnon GL, Parker WA. 1982; Benzodiazepine withdrawal syndrome: a literature review and evaluation. [Review]. Am J Drug Alcohol Abuse 1992; 9: 19-33.
120. Malitz S, Wilkens B, Esecover H. A comparison of drug-induced hallucinations with those seen in spontaneously occurring psychoses. In: West LJ, editor. Hallucinations. New York: Grune & Stratton; 1963. p. 50-63.
121. Mantovani P, Pepeu G. Influence of dopamine agonists on cholinergic mechanisms in the cerebral cortex. In: Garrattini S, editor. Interactions between putative neurotransmitters in the brain. New York: Raven Press; 1978. p. 53-9.
122. Mathers LH. Ultrastructure of the pulvinar of the squirrel monkey. J Comp Neurol 1972; 146: 15-42.
123. Matthews TD, Kennard C. Residual vision following geniculostriate lesions. [Review]. Baillieres din Neurol 1993; 2: 227-41.
124. Maury A. Des hallucinations hypnagogiques, ou des erreurs des sens dans l'état intermédiaire entre la veille et le sommeil. Ann Medico-Psychol 1848; VII: 26-40.
125. McCabe MS, Fowler RC, Cadoret RJ, Winokur G. Symptom differences in schizophrenia with good and poor prognosis. Am J Psychiatry 1972; 128: 1239-43.
126. McCarley RW, Benoit O, Barrionuevo G. Lateral geniculate nucleus unitary discharge in sleep and waking: state- and rate-specific aspects. J Neurophysiol 1983; 50: 798-818.
127. McKee AC, Levine DN, Kowall NW, Richardson EP Jr. Peduncular hallucinosis associated with isolated infarction of the substantia nigra pars reticulata. Ann Neurol 1990; 27: 500-4.
128. McShane R, Gedling K, Reading M, McDonald B, Esiri MM, Hope T. Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1995; 59: 185-8.
129. Meco G, Bonifati V, Cusimano G, Fabrizio E, Vanacore N. Hallucinations in Parkinson disease: neuropsychological study. Italian Journal of Neurological Sciences 1990; 11: 373-9.
130. Meco G, Alessandria A, Bonifati V, Giustini P. Risperidone for hallucinations in levodopa-treated Parkinson's disease patients [letter] [see comments]. Lancet 1994; 343: 1370-1 Comment in: Lancet 1994; 344: 681.
131. Meco G, Alessandria A, Bonifati V, Giustini P. Risperidone for hallucinations in levodopa-treated Parkinson's disease patients [letter] [see comments]. Lancet 1994; 343: 1370-1 Comment in: Lancet 1994; 344: 681.
132. Melzack R, Israel R, Lacroix R, Schultz G. Phantom limbs in people with congenital limb deficiency or amputation in early childhood. Brain 1997; 120: 1603-20.
133. Meyer JS, Sakai F, Karacan I, Derman S, Yamamoto M. Sleep apnea, narcolepsy, and dreaming: regional cerebral hemodynamics. Ann Neurol 1980; 7: 479-85.
134. Mitchell SW. The effects of Anhelonium lewinii (The mescal button). Br Med J 1896; 2: 1625-9.
135. Morrison JH, Foote SL. Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys. J Comp Neurol 1986; 243: 117-38.
136. Mouret J. Differences in sleep in patients with Parkinson's disease. Electroencephalogr Clin Neurophysiol 1975; 38: 653-7.
137. Mueser KT, Bellack AS, Brady EU. Hallucinations in schizophrenia. Acta Psychiatr Scand 1990; 82: 26-9.
138. Myslobodsky M, Mintz M, Ben-Mayor V, Radwan H. Unilateral dopamine deficit and lateral EEC asymmetry: sleep abnormalities in hemi-Parkinson's patients. Electroencephalogr Clin Neurophysiol 1982; 54: 227-31.
139. Nadvi SS, Van Dellen JR. Transient peduncular hallucinations secondary to brain stem compression by a medulloblastoma. Surg Neurol 1994; 41: 250-2.
140. Nausieda PA, Tanner CM, Klawans HL. Serotonergically active agents in levodopa-induced psychiatric toxicity reactions. Adv Neurol 1983; 37: 23-32.
141. Ndetei DM, Singh A. Hallucinations in Kenyan schizophrenic patients. Acta Psychiatr Scand 1983; 67: 144-7.
142. Nevo I, Hamon M. Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. [Review]. Neurochem Int 1995; 26: 305-36.
143. Ogren MP, Hendrickson AE. The structural organization of the inferior and lateral subdivisions of the Macaca monkey pulvinar. J Comp Neurol 1979; 188: 147-78.
144. Ophoff RA, Terwindt GM, Vergouwe MN, vam Eijk R, Oefner PJ, Hoffman SM, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the calcium channel gene CACNL1A4. Cell 1996; 87: 543-52.
145. Parent A. Carpenter's human neuroanatomy. Baltimore: Williams & Wilkins; 1996.
146. Parent A, Pare D, Smith Y, Steriade M. Basal forebrain cholinergic and noncholinergic projections to the thalamus and brainstem in cats and monkeys. J Comp Neurol 1988; 277: 281-301.
147. Pasik P, Molinar-Rode R, Pasik T. Chemically specified systems in the dorsolateral geniculate nucleus of mammals. In: Cohen B, Bodis-Wollner I, editors. Vision and the brain. New York: Raven Press; 1990. p. 43-83.
148. Penfield W, Jasper HH. Epilepsy and the functional anatomy of the human brain. Boston: Little, Brown; 1954.
149. Penfield W, Perot P. The brain's record of auditory and visual experience. Brain 1963; 86: 595-696.
150. Perry EK, Marshall E, Kerwin J, Smith CJ, Jabeen S, Cheng AV, et al. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. J Neurochem 1990; 55: 1454-6.
151. Perry EK, McKeith I, Thompson P, Marshall E, Kerwin J, Jabeen S, et al. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann N Y Acad Sci 1991; 640: 197-202.
152. Perry EK, Marshall E, Thompson P, McKeith IG, Collerton D, Fairbairn AF, et al. Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. J Neural Transm Park Dis Dement Sect 1993; 6: 167-77.
153. Plazzi G, Montagna P, Provini F, Bizzi A, Cohen M, Lugaresi E. Pontine lesions in idiopathic narcolepsy. Neurology 1996; 46: 1250-4.
154. Porteous HB, Ross DN. Mental symptoms in parkinsonism following benzhexol hydrochloride therapy. Br Med J 1956; 2: 138-40.
155. Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L. Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study. Magn Reson Med 1995; 33: 595-600.
156. Ritchie Russell W, Whitty CWM. Studies in traumatic epilepsy. 3. Visual fits. J Neurol Neurosurg Psychiatry 1955; 18: 79-96.
157. Rivera VM, Meyer JS, Hata T, Ishikawa Y, Imai A. Narcolepsy following cerebral hypoxic ischemia. Ann Neurol 1986; 19: 505-8.
158. Robinson DL, Petersen SE. The pulvinar and visual salience. [Review]. Trends Neurosci 1992; 15: 127-32.
159. Rodrigo-Angulo MI, Reinoso-Suarez F. Topographical organization of the brainstem afferents to the lateral posterior-pulvinar thalamic complex in the cat. Neuroscience 1982; 7: 1495-508.
160. Rogawski MA, Aghajanian GK. Norepinephrine and serotonin: opposite effects on the activity of lateral geniculate neurons evoked by optic pathway stimulation. Exp Neurol 1980; 69: 678-94.
161. Rondot P, de Recondo J, Coignet A, Ziegler M. Mental disorders in Parkinson's disease after treatment with L- DOPA. Adv Neurol 1984; 40: 259-69.
162. Rosenthal SH. Persistent hallucinosis following repeated administration of hallucinogenic drugs. Am J Psychiatry 1964; 121: 238-44.
163. Roth BL, Meltzer HY. The role of serotonin in schizophrenia. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995. p. 1215-27.
164. Rozanski J. Peduncular hallucinosis following vertebral angiography. Neurology 1952; 2: 341-9.
165. Ruch-Monachon MA, Jalfre M, Haefely W. Drugs and PGO waves in the lateral geniculate body of the curarized cat. II. PGO wave activity and brain 5-hydroxytryptamine. Arch Int Pharmacodyn 1976; 219: 269-86.
166. Sacks OW, Kohl MS, Messeloff CR, Schwartz WF. Effects of levodopa in parkinsonian patients with dementia. Neurology 1972; 22: 517-9.
167. Sakai F, Meyer JS, Karacan I, Yamaguchi F, Yamamoto M. Narcolepsy: regional cerebral blood flow during sleep and wakefulness. Neurology 1979; 29: 61-7.
168. Salanova V, Andermann F, Olivier A, Rasmussen T, Quesney LF. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Surgery of occipital lobe epilepsy. Brain 1992; 115: 1655-80.
169. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease [see comments]. Arch Neurol 1996; 53: 1265-8. Comment in: Arch Neurol 1997; 54: 799.
170. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease [see comments]. Arch Neurol 1996; 53: 1265-8. Comment in: Arch Neurol 1997; 54: 799.
171. Schmidt HS, Clark RW, Hyman PR. Protriptyline: an effective agent in the treatment of the narcolepsy-cataplexy syndrome and hypersomnia. Am J Psychiatry 1977; 134: 183-5.
172. Schmidt CJ, Black CK, Taylor VL. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylene-dioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats. Eur J Pharmacol 1991; 203: 41-9X.
173. Schultz G, Melzack R. The Charles Bonnet syndrome: 'phantom visual images'. [Review]. Perception 1991; 20: 809-25.
174. Schultz G, Needham W, Taylor R, Shindell S, Melzack R. Properties of complex hallucinations associated with deficits in vision. Perception 1996; 715-26.
175. Serra Catafau J, Rubio F, Peres Serra J. Peduncular hallucinosis associated with posterior thalamic infarction. J Neurol 1992; 239: 89-90.
176. Siegel JM. Brainstem mechanisms generating REM sleep. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 2nd ed. Philadelphia: W. B. Saunders; 1994. p. 125-44.
177. Singer W. Control of thalamic transmission by corticofugal and ascending reticular pathways in the visual system. [Review]. Physiol Rev 1977; 57: 386-420.
178. Small IJ, Small JG, Andersen JM. Clinical characteristics of hallucinations of schizophrenia. Dis Nerv Syst 1966; 27: 349-53.
179. Solms M. The neuropsychology of dreams. Hillsdale (NJ): Lawrence Erlbaum; 1997a. p. 205.
180. Solms M. The classic case reports of Charcot-Willebrand syndrome. In: Solms M. The neuropsychology of dreams. Hillsdale (NJ): Lawrence Erlbaum; 1997b. p. 4-19.
181. Sowa MV, Pituck S. Prolonged spontaneous complex visual hallucinations and illusions as ictal phenomena. Epilepsia 1989; 30: 524-6.
182. Stahl SM, Layzer RB, Aminoff MJ, Townsend JJ, Feldon S. Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology 1980; 30: 1115-8.
183. Steckler T, Sahgal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. [Review]. Behav Brain Res 1995; 67: 165-99.
184. Steriade M, Pare D, Bouhassira D, Deschenes M, Oakson G. Phasic activation of lateral geniculate and perigeniculate thalamic neurons during sleep with ponto-geniculo-occipital waves. J Neurosci 1989; 9: 2215-29.
185. Sweet RD, McDowell FH, Feigenson JS, Loranger AW, Goodell H. Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology 1976; 26: 305-10.
186. Taylor J, Holmes G, Walshe FMR, editors. Selected writings of John Hughlings Jackson, Vol. 1. On epilepsy and epileptiform convulsions. London: Hodder & Stoughton; 1931.
187. Taylor J, Holmes G, Walshe FMR. Evolution and dissolution of the nervous system. In: Taylor J, Holmes G, Walshe FMR, editors. Selected writings of John Hughlings Jackson, Vol 2. London: Hodder & Stoughton; 1932. p. 3-120.
188. Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996; 347: 794-7.
189. Tournay A. Sur mes propres visions du demi-sommeil. Rev Neurol (Paris) 1941; 73: 209-24.
190. Tsoukatos J, Kiss ZH, Davis KD, Tasker RR, Dostrovsky JO. Patterns of neuronal firing in the human lateral thalamus during sleep and wakefulness. Exp Brain Res 1997; 113: 273-82.
191. Tsukamoto H, Matsushima T, Fujiwara S, Fukui M. Peduncular hallucinosis following microvascular decompression for trigeminal neuralgia: case report. Surg Neurol 1993; 40: 31-4.
192. Turner TH, Cookson JC, Wass JA, Drury PL, Price PA, Besser GM. Psychotic reactions during treatment of pituitary tumours with dopamine agonists. Br Med J 1984; 289: 1101-3.
193. Van Bogaert L. Syndrome inferieur du noyau rouge, troubles psychosensoriels d'origine mesocephalique. Rev Neurol (Paris) 1924; 1: 417-23.
194. Van Bogaert L. L'hallucinose pedonculaire. Rev Neurol (Paris) 1927; 1: 608-17.
195. Vaphiades MS, Celesia GG, Brigell MG. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology 1996; 47: 408-17.
196. Victor M, Adams RD. The effect of alcohol on the nervous system. In: Merritt HH, Hare CC, editors. Metabolic and toxic disease of the nervous system. Baltimore: Williams and Wilkins; 1952. p. 526-73.
197. Vizuete ML, Steffen V, Machado A, Cano J. Effects of neonatal enucleation on catecholamine and serotonin turnover and amino acid levels in lateral geniculate nucleus and visual cortex of the adult rat. Brain Res 1992; 575: 231-7.
198. Walker MC, Smith SJ, Sisodiya SM, Shorvon SD. Case of simple partial status epilepticus in occipital lobe epilepsy misdiagnosed as migraine: clinical, electrophysiological, and magnetic resonance imaging characteristics. Epilepsia 1995; 36: 1233-6.
199. Welch KM, Barkley GL, Tepley N, Ramadan NM. Central neurogenic mechanisms of migraine. [Review]. Neurology 1993; 43 (6 Suppl 3): S21-5.
200. Williams J, McGuffin P, Nothen M, Owen MJ. Meta-analysis of association between 5-HT2a receptor T102C polymorphism and schizophrenia [letter]. Lancet 1997; 349: 1221.
201. Williamson PD, Boon PA, Thadani VM, Darcey TM, Spencer DD, Spencer SS, et al. Parietal lobe epilepsy: diagnostic considerations and results of surgery. Ann Neurol 1992; 31: 193-201.
202. Wilson JR. Circuitry of the dorsal lateral geniculate nucleus in the cat and monkey. [Review]. Acta Anat (Basel) 1993; 147: 1-13.
203. Wyatt RJ, Fram DH, Buchbinder R, Snyder F. Treatment of intractable narcolepsy with a monoamine oxidase inhibitor. N Engl J Med 1971; 285: 987-91.
204. Xuereb JH, Tomlinson BE, Irving D, Perry RH, Blessed G, Perry EK. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. Adv Neurol 1990; 53: 35-40.
205. Young BG. A phenomenological comparison of LSD and schizophrenic states. Br J Psychiatry 1974; 124: 64-74.
206. Zarroug E-TA. The frequency of visual hallucinations in schizophrenic patients in Saudi Arabia. Br J Psychiatry 1975; 127: 553-5.
207. Zifkin B, Andermann E, Andermann F, Kirkham T. An autosomal dominant syndrome of hemiplegic migraine, nystagmus, and tremor. 1980; Ann Neurol 8: 329-32.